**Chapter 5**

Psikhiatrii Imeni S.S. Korsakova. 2017;

*Neurostimulation and Neuromodulation in Contemporary Therapeutic Practice*

[48] Sinelnikov RD. Atlas of Human Anatomy. Vol. 1. Moscow; 1978. 472 pp

[49] Shevkunenko VN. Short Course of Operative Surgery with Topographic Anatomy. Leningrad; 1947. 567 pp

[50] Borg J, Ward AB, Wissel J, et al. Rationale and design of a multicentre, double-blind, prospective, randomized,

Evaluating patient outcomes and costs of managing adults with post-stroke focal spasticity. Journal of Rehabilitation Medicine. 2011;**43**(1):15-22. DOI:

[51] Dashtipour K, Chen JJ, Walker HW, Lee MY. Systematic literature review of Abobotulinumtoxin A in clinical trials for lower limb spasticity. Medicine (Baltimore). 2016;**95**(2):e2468. DOI: 110.1097/MD.0000000000002468

[52] Misikov VK. The preparations of Botulinum toxin type A in the treatment of lower limb post-stroke spasticity. Clinical Observation. 2014;**3**:49-51. DOI: 10.17650/2222-8721-2014-0-3-49-51

[53] Gracies J-M, Esquenazi A, Brashear A, Banach M, Kocer S, Jech R, et al.

abobotulinumtoxin A in spastic lower

[54] Wissel J, Ward AB, Erztgaard P, Bensmail D, Hecht MJ, Lejeune TM, et al. European consensus table on the use of botulinum toxin type A in adult spasticity. Journal of Rehabilitation Medicine. 2009;**41**(1):13-25. DOI:

Efficacy and safety of

limb. 2017. DOI: 10.1212/ WNL.0000000000004687

10.2340/16501977-0303

**86**

European and Canadian study:

110.2340/16501977-0663

**117**(7):47-52. DOI: 10.17116/ jnevro20171177147-52
